OTC Annual Report Filed-Change of Management
The original release is unavailable here.
Earlier from iBrands
- iBrands Corporation Enhances Net Stockholder Equity
- iBrands Corporation Address To Shareholders
- iBrands Corporation Letter to Shareholders January 2020
- iBrands Corporation Enters Into Industrial Hemp Farming Sector
- iBrands Corporation Enters Into Long-Term Construction Contract
Later from iBrands
- iBrands Corporation Enters Into Distribution Agreement With Medical Supply Group
- iBrands Corporation Adds Immune Booster To Nutraceutical Product Line
- iBrands Corporation Announces Clinical Trial For Immune Booster Product
- iBrands Corporation Reports QuadraMune Reduces Myeloid Suppressor Cells in 4T1 Mouse Model of Breast Cancer
- iBrands Corporation Reports Reduction of Brain Inflammation/Depression Associated Biochemical Pathway Using QuadraMune™ in Animal Studies
Follow iBrands into a list and get an email when it puts out news.
Follow iBrands